SageView Advisory Group LLC Grows Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

SageView Advisory Group LLC grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 108.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,116 shares of the company’s stock after purchasing an additional 1,102 shares during the quarter. SageView Advisory Group LLC’s holdings in HCA Healthcare were worth $573,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently made changes to their positions in HCA. Stone House Investment Management LLC bought a new position in shares of HCA Healthcare during the 3rd quarter valued at approximately $25,000. Centerpoint Advisors LLC bought a new position in HCA Healthcare in the 4th quarter worth approximately $27,000. Atlantic Edge Private Wealth Management LLC bought a new position in HCA Healthcare in the 4th quarter worth approximately $27,000. Bruce G. Allen Investments LLC bought a new position in HCA Healthcare in the 4th quarter worth approximately $28,000. Finally, FinTrust Capital Advisors LLC boosted its stake in HCA Healthcare by 26.7% in the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock worth $45,000 after purchasing an additional 35 shares during the period. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

HCA stock opened at $340.65 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26. The business’s fifty day simple moving average is $321.29 and its two-hundred day simple moving average is $313.85. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $343.53. The firm has a market cap of $89.22 billion, a price-to-earnings ratio of 16.98, a PEG ratio of 1.56 and a beta of 1.69.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating the consensus estimate of $5.01 by $0.35. The firm had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The firm’s quarterly revenue was up 11.2% on a year-over-year basis. During the same period in the previous year, the company posted $4.93 earnings per share. Analysts predict that HCA Healthcare, Inc. will post 20.92 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 annualized dividend and a dividend yield of 0.77%. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 6,311 shares of HCA Healthcare stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $316.88, for a total value of $1,999,829.68. Following the transaction, the executive vice president now owns 29,624 shares in the company, valued at $9,387,253.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total transaction of $303,576.00. Following the completion of the transaction, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Michael S. Cuffe sold 6,311 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $316.88, for a total value of $1,999,829.68. Following the sale, the executive vice president now owns 29,624 shares of the company’s stock, valued at $9,387,253.12. The disclosure for this sale can be found here. Insiders sold 12,397 shares of company stock worth $3,921,929 over the last three months. 1.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

HCA has been the subject of several recent analyst reports. Cantor Fitzgerald restated an “overweight” rating and issued a $335.00 price target on shares of HCA Healthcare in a research note on Wednesday, April 10th. Royal Bank of Canada increased their target price on HCA Healthcare from $322.00 to $329.00 and gave the company an “outperform” rating in a research report on Monday, April 29th. Wells Fargo & Company increased their target price on HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research report on Thursday, March 28th. Baird R W upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, Robert W. Baird initiated coverage on HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price for the company. Four investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $325.59.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.